Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
Luoyan Ai, Antao Xu, Jie Xu
Advances in experimental medicine and biology (2020), pp. 33-59
Closed Access | Times Cited: 382

Showing 1-25 of 382 citing articles:

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment
Han Luo, Xuyang Xia, Li‐Bin Huang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 281
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
Tang Qing, Yun Chen, Xiaojuan Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 275
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 181
The oral microbiota and its role in carcinogenesis
Mark Stasiewicz, Tomasz M. Karpiński
Seminars in Cancer Biology (2021) Vol. 86, pp. 633-642
Open Access | Times Cited: 159
Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion
Wenli Fang, Ting Zhou, He Shi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 147
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Matteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 133-157
Closed Access | Times Cited: 146
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Kun Pang, Zhenduo Shi, Liuya Wei, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100907-100907
Closed Access | Times Cited: 113
Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang, Hui Geng, Yujie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 96
Protein acylation: mechanisms, biological functions and therapeutic targets
Shuang Shang, Jing Liu, Fang Hua
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 94
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
Adil Parvez, Furqan Choudhary, Priyal Mudgal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 67
The role of PD-1 signaling in health and immune-related diseases
Ruyue Chen, Yun Zhu, Yunyan Shen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 25
Genetic expression in cancer research: Challenges and complexity
Hengrui Liu, Zheng Guo, Panpan Wang
Gene Reports (2024), pp. 102042-102042
Closed Access | Times Cited: 24
Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death
Xu Liu, Yichao Lu, Xiang Li, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1058-1073
Closed Access | Times Cited: 23
Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation
Peng Deng, Xiaodan Dong, Ziyuan Wu, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 23
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Chun Ye, Xiao Liu, Zilun Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 22
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
PD-1 regulation in immune homeostasis and immunotherapy
Minling Gao, Jie Shi, Xiangling Xiao, et al.
Cancer Letters (2024) Vol. 588, pp. 216726-216726
Closed Access | Times Cited: 16
Skull Base Chordomas and Chondrosarcomas
Natalia Kremenevski, Sven-Martin Schlaffer, Roland Coras, et al.
Neuroendocrinology (2020) Vol. 110, Iss. 9-10, pp. 836-847
Open Access | Times Cited: 78
Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
Kaijian Zhou, Shu Guo, Fei Li, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 76
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
Shuyue Wang, Kun Xie, Tengfei Liu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 75
CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer
Xingyu Chen, Runshi Xu, Dong He, et al.
Oncogene (2021) Vol. 40, Iss. 43, pp. 6223-6234
Closed Access | Times Cited: 67
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
Chang Liu, Navindra P. Seeram, Hang Ma
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
Yefang Lao, Daoming Shen, Weili Zhang, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3575-3575
Open Access | Times Cited: 48
Exploring animal models in oral cancer research and clinical intervention: A critical review
Danial Khayatan, Ahmed Hussain, Hamid Tebyaniyan
Veterinary Medicine and Science (2023) Vol. 9, Iss. 4, pp. 1833-1847
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top